About Anti-counterfeit Packaging in Pharmaceutical Industry
Anti-counterfeit packaging is a process carried out to secure the packaging of products to reduce infringement. The demand for anti-counterfeit packaging in the pharmaceutical industry is increasing. With a growing initiative by technology vendors in the market, the pharmaceutical companies have an opportunity to fight against counterfeit issues. For instance, in 2016, Applied DNA Sciences, a security and authentication solutions provider, introduced SigNature DNA Molecular taggant for the pharmaceutical supply chain.
Technavio’s analysts forecast the global anti-counterfeit packaging market in pharmaceutical industry to grow at a CAGR of 21.36% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global anti-counterfeit packaging market in pharmaceutical industry for 2017-2021. To calculate the market size, the report considers the revenue generated by different vendors through the sales of various technologies that include covert technologies and overt technologies.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Anti-counterfeit Packaging Market in Pharmaceutical Industry 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• 3M
• Avery Dennison
• CCL Industries
• DuPont
Other prominent vendors
• Aesica
• Applied DNA Sciences
• ATL (Ad Tape & Label)
• Atlantic Zeiser
• Authentix
• Essentra
Market driver
• Rising online purchase of medicines
• For a full, detailed list, view our report
Market challenge
• Rising price of prescription-based drugs
• For a full, detailed list, view our report
Market trend
• Growing initiatives by pharmaceutical companies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by types of technology
• Global anti-counterfeit packaging in the pharmaceutical industry by types of technology
• Global anti-counterfeit packaging in the pharmaceutical industry by covert technologies
• Global anti-counterfeit packaging in the pharmaceutical industry by overt technologies
PART 07: Market segmentation by types of drug
• Global anti-counterfeit packaging in the pharmaceutical industry by types of drug
• Global anti-counterfeit packaging in the pharmaceutical industry by OTC drugs
• Global anti-counterfeit packaging in the pharmaceutical industry by prescription-based drugs
PART 08: Geographical segmentation
• Global anti-counterfeit packaging in the pharmaceutical industry by geography
• Anti-counterfeit packaging in the pharmaceutical industry in the Americas
• Anti-counterfeit packaging in the pharmaceutical industry in APAC
• Anti-counterfeit packaging in the pharmaceutical industry in EMEA
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
PART 12: Vendor landscape
• Competitive scenario
• 3M
• Avery Dennison
• CCL Industries
• DuPont
• Other prominent vendors
PART 13: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global anti-counterfeit packaging in the pharmaceutical industry in the global anti-counterfeit packaging market 2016 (% revenue)
Exhibit 02: Counterfeiting issues in several industries
Exhibit 03: Global anti-counterfeit packaging in the pharmaceutical industry
Exhibit 04: Global anti-counterfeit packaging in the pharmaceutical industry 2016-2021 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global anti-counterfeit packaging in the pharmaceutical industry by types of technology 2016 (% revenue)
Exhibit 07: Global anti-counterfeit packaging in the pharmaceutical industry by types of technology 2016-2021 (% revenue)
Exhibit 08: Global anti-counterfeit packaging in the pharmaceutical industry by types of technology growth 2017-2021 (%)
Exhibit 09: Global anti-counterfeit packaging in the pharmaceutical industry by covert technologies 2016-2021 ($ billions)
Exhibit 10: Global anti-counterfeit packaging in the pharmaceutical industry by overt technologies 2016-2021 ($ billions)
Exhibit 11: Global anti-counterfeit packaging in the pharmaceutical industry by types of drug 2016 (% revenue)
Exhibit 12: Global anti-counterfeit packaging in the pharmaceutical industry by types of drug 2016-2021 (% revenue)
Exhibit 13: Global anti-counterfeit packaging in the pharmaceutical industry by types of drug growth 2017-2021
Exhibit 14: Global anti-counterfeit packaging in the pharmaceutical industry by OTC drugs 2016-2021 ($ billions)
Exhibit 15: Global anti-counterfeit packaging in the pharmaceutical industry by prescription-based drugs 2016-2021 ($ billions)
Exhibit 16: Global anti-counterfeit packaging in the pharmaceutical industry by geography 2016 (% revenue)
Exhibit 17: Global anti-counterfeit packaging in the pharmaceutical industry by geography 2016-2021 (% revenue)
Exhibit 18: Global anti-counterfeit packaging in the pharmaceutical industry by geography growth 2017-2021
Exhibit 19: Anti-counterfeit packaging in the pharmaceutical industry in the Americas 2016-2021 ($ billions)
Exhibit 20: Number of foreign inspections by FDA 2010-2015
Exhibit 21: Anti-counterfeit packaging in the pharmaceutical industry in APAC 2016-2021 ($ billions)
Exhibit 22: Anti-counterfeit packaging in the pharmaceutical industry in EMEA 2016-2021 ($ billions)
Exhibit 23: Counterfeit medicines rise
Exhibit 24: Prescription drugs prices
Exhibit 25: Initiatives by pharmaceutical companies
Exhibit 26: Avery Dennison: Geographical segmentation 2016 (% revenue)
Exhibit 27: Avery Dennison: Label and graphic materials solutions
Exhibit 28: Avery Dennison: Retail branding and information solutions
Exhibit 29: Avery Dennison: Industrial and healthcare materials solutions
Exhibit 30: Avery Dennison: Business segmentation 2016 (% revenue)
Exhibit 31: CCL Industries: Geographical segmentation 2016 (% revenue)
Exhibit 32: CCL Industries: Business segmentation 2016 (% revenue)
Exhibit 33: DuPont: Business segmentation 2016 (% revenue)
